Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 46.80 [1]. Core Views - The company achieved a revenue of HKD 14.58 billion in 2025, representing a year-on-year growth of 11.5%, and a net profit of HKD 980 million, up 14.8% year-on-year, slightly exceeding previous expectations [1]. - The company's robust revenue growth amidst external disruptions is attributed to improved gross margins in leaf and cigarette exports, indicating a strong operational performance [1]. - As the only listed platform under China Tobacco, the company has a strong competitive moat and is expected to continue its growth trajectory in core business areas, supported by ongoing breakthroughs in leaf and cigarette export operations [1]. Revenue and Profitability - The combined revenue from leaf import and export business reached HKD 12.02 billion in 2025, a year-on-year increase of 16.5%, accounting for 82.4% of total revenue [2]. - The leaf import business generated HKD 9.54 billion in revenue, up 15.6% year-on-year, driven by an increase in average selling prices despite a slight decline in import volume [2]. - The leaf export business saw revenue of HKD 2.48 billion, a 20.4% increase year-on-year, with both export volume and average price rising, benefiting from enhanced customized services and pricing strategies [2]. Sales Performance - The cigarette export business generated HKD 1.67 billion in revenue, reflecting a 5.9% year-on-year increase, although export volume decreased by 3.3% due to shipping rhythm impacts [3]. - New tobacco product exports faced significant declines, with volumes down 51.2% year-on-year, resulting in a revenue drop of 52.5% [3]. - The company's operations in Brazil reported a revenue of HKD 830 million, down 21.0% year-on-year, primarily due to shipping rhythm and market changes [3]. Profitability Metrics - The overall gross margin for the company was 10.1% in 2025, a decrease of 0.4 percentage points year-on-year, mainly due to the higher proportion of lower-margin leaf import and export business [4]. - The net profit margin for the company was 6.7%, an increase of 0.2 percentage points year-on-year, supported by reduced management and financial expense ratios [4]. - The company has announced several important updates indicating ongoing progress in its export business, suggesting continued growth potential [4]. Earnings Forecast and Valuation - The earnings forecast for 2026-2028 has been slightly adjusted downwards, with expected net profits of HKD 1.08 billion, HKD 1.20 billion, and HKD 1.32 billion respectively [5]. - The company is assigned a target PE of 30 times for 2026, reflecting its unique market position and long-term growth potential, with a revised target price of HKD 46.80 [5].

Core Viewpoint - The A-share brokerage sector is experiencing significant profit growth, with 17 listed brokerages reporting an average net profit of 5.85 billion yuan for 2025, reflecting a year-on-year increase of 92.92% [1] Group 1: Performance of Leading Brokerages - Four leading brokerages, including CITIC Securities and Guotai Junan, are expected to report net profits exceeding 10 billion yuan, driven by resilience in self-operated, wealth management, and investment banking sectors [2] - Shenwan Hongyuan anticipates a net profit of 10.1 billion to 11.1 billion yuan for 2025, marking a year-on-year growth of 61.59% to 77.59% [2] - Guotai Junan expects a net profit of 27.53 billion to 28.01 billion yuan, representing a year-on-year increase of 111% to 115% [3] Group 2: Performance of Smaller Brokerages - Among smaller brokerages, Guolian Minsheng reported a net profit of 2.01 billion yuan, a staggering increase of approximately 406% [5] - Other smaller brokerages, such as Huaxi Securities and Hongta Securities, also showed strong performance with net profit growth exceeding 50% [5] - However, companies like Guorong Securities and Zhongshan Securities faced significant declines in net profit, highlighting a disparity in performance within the sector [6] Group 3: Market Conditions and Valuation - Despite strong earnings, brokerage stock prices have remained stagnant, indicating a mismatch between profitability and valuation [7] - The A-share brokerage index rose by 4% in 2025, while the CSI 300 index increased by 18%, suggesting potential for valuation recovery [8] - Analysts predict that the brokerage sector still holds strategic allocation value, with expectations for significant valuation recovery [8] Group 4: Future Outlook - The sector is expected to benefit from favorable policies aimed at stabilizing growth and boosting the capital market, alongside a conducive liquidity environment [9] - The current low valuation levels present opportunities for defensive rebounds, with recommendations to focus on strong leading brokerages and those with competitive advantages in wealth management and proprietary trading [10]

Core Viewpoint - The company, Meikang Bio (300439), is in the early stages of developing its international business, facing challenges related to market access and channel development [1] Group 1: International Business Development - The company has initiated a systematic construction of its international business since 2024, forming a specialized team for international registration and market expansion [1] - Initial results are expected in 2025 from market development efforts in emerging markets such as Russia, Turkey, the Philippines, and Vietnam [1] - The company aims to enhance its overall competitiveness in international markets by continuously strengthening team capabilities and accelerating product registration and certification in key markets [1]

Core Viewpoint - The company is expanding its international sales and service network, focusing on localization strategies to enhance its global presence and customer service capabilities [2] Group 1: International Expansion - The company has established localized sales and service points in over twenty key countries and regions [2] - The focus areas for the company's international business include Southeast Asia, Middle East and Africa, Europe, Americas, and India and Australia [2] - The company aims to achieve significant growth in export orders by 2025 compared to 2024 [2] Group 2: Competitive Advantages - The company leverages its unique overall solution capabilities, high cost-performance services, and channel advantages to expand its customer base [2]

Core Viewpoint - The securities ETF (159841) has shown significant performance with a turnover of 3.45% and a transaction volume of 358 million yuan, reflecting a positive trend in the securities sector as the underlying index rises by 0.45% [1][2]. Group 1: ETF Performance - As of January 20, the securities ETF (159841) reached a new high with a total size of 10.458 billion yuan and 9.555 billion shares outstanding, marking a one-month peak [2]. - The ETF has experienced continuous net inflows over the past five days, with a maximum single-day net inflow of 203 million yuan, totaling 650 million yuan in net inflows [2]. Group 2: Market Trends - The securities ETF tracks the CSI All Share Securities Companies Index, with the top ten constituent stocks accounting for over 60% of the index weight, providing direct exposure to leading brokerage firms benefiting from the recovery of the A-share market [2]. - The monthly active users of securities-related apps reached 175 million in December 2025, representing a month-on-month increase of 1.75% and a year-on-year increase of 2.26%, setting a new monthly record for 2025 [2]. Group 3: Institutional Insights - China Galaxy Securities believes that the government's policies aimed at "stabilizing growth and the stock market" will continue to shape the future direction of the sector, supported by a moderately loose liquidity environment and an ongoing optimization of the capital market [2]. - The current market environment is characterized by high levels of market activity and a "healthy bull" trend, with factors such as wealth management transformation, international business expansion, and financial technology empowerment expected to drive improvements in the industry's return on equity (ROE) [2].

Group 1 - The company is currently building an international business management platform and developing a strategic plan for international business growth [1] - The company aims to seize opportunities from the transfer of the manufacturing industry and systematically layout overseas markets [1] - The strategy includes both "borrowing a ship to go to sea" and "building a ship to go to sea," focusing on promoting high-tech industry services and railway communication terminal products abroad [1]

Group 1 - Hong Kong MTR Corporation (MTR) and a subsidiary of CRRC Corporation have formed a joint venture, Metro Trains West, to secure the Sydney Metro West contract from the New South Wales government [1] - The Sydney Metro West project is a new 24-kilometer metro line with 9 stations, scheduled to commence operations in 2032, with MTR responsible for various delivery phases including design, construction, and maintenance [1][3] - The contract includes the provision of 16 driverless trains and a signaling system, along with 15 years of operation and maintenance services during the trial operation phase [1] Group 2 - CRRC's subsidiary, CRRC Changchun Railway Vehicles, has been active in the Australian metro market for over a decade, establishing a local presence and previously delivering 65 high-capacity metro trains for the HCMT project in Victoria [2] - The Sydney Metro West project encompasses four core contracts, with a total value of AUD 11.5 billion, including equipment, operation, and maintenance, as well as track systems and station development [3] - CRRC's international business has seen a high volume of orders, with new international orders amounting to approximately CNY 47.2 billion in 2024, despite a year-on-year decrease of 19.18% [3]

Group 1 - The A-share market continues its longest winning streak, with the Shanghai Composite Index reaching a 10-year high of 4085.77 points, marking 14 consecutive days of gains and nearing the 4100-point mark [1][7] - A significant sell order of 492,200 lots from CITIC Securities, valued at approximately 1.45 billion yuan, was observed near the market close, indicating potential selling pressure [1][7] - Previous instances of large sell orders from CITIC Securities were noted, with over 3 billion yuan and 1 billion yuan in sell orders recorded on September 17 and October 24, 2025, respectively [1][7] Group 2 - The brokerage sector experienced a notable surge, with a total inflow of 14.549 billion yuan, leading all secondary industries in the Shenwan classification [4][8] - Major brokerages, including CITIC Securities, received over 1 billion yuan in inflows, with Oriental Fortune seeing a net financing buy of 955 million yuan, the highest in over three months [4][8] - The market outlook remains positive, driven by government policies aimed at stabilizing growth and boosting the capital market, alongside a favorable liquidity environment and improved investor confidence [9]

Core Viewpoint - Mindray Medical anticipates that by the first three quarters of 2025, international business will account for over half of the company's total revenue, with a continuous increase expected in the coming years [1] Group 1: International Business Growth - The company is focusing on localized platform development, which is expected to enhance the proportion of international revenue in overall income [1] - Developing countries are projected to maintain a rapid growth trend in terms of international revenue [1] Group 2: Profitability and Client Structure - The proportion of high-end clients within the revenue structure is expected to continue increasing, which may lead to a steady improvement in the profitability of international business [1] - Detailed financial information will be available in the annual report scheduled for release on March 31, 2026 [1]

Core Viewpoint - The stock market is experiencing a strong upward trend, with the Shanghai Composite Index rising 1.5% and achieving a remarkable 13 consecutive days of gains, breaking through the previous high from November 14, 2025, and reaching the highest level in over 10 years since July 2015 [1][9]. Market Performance - The total trading volume in the Shanghai and Shenzhen markets reached 2.83 trillion yuan, marking the sixth consecutive trading day exceeding 2 trillion yuan, indicating increased market activity [1][9]. - The brokerage sector has seen a significant surge, with stocks like Huayin Securities and Huashan Securities hitting the daily limit, while others like Changjiang Securities and Guotai Junan rose over 6% [1][9]. - Dongfang Caifu's stock surged by 5.73%, achieving a trading volume of 22.367 billion yuan, making it the top stock in A-shares [1][9]. - The leading brokerage ETF (512000) saw a price increase of 4.07%, the largest single-day gain since October 2025, with a trading volume of 3.393 billion yuan, reflecting a 146% increase in volume [1][9]. Capital Inflow - The brokerage sector attracted a net inflow of 14.549 billion yuan from major funds, leading all secondary industries in the Shenwan classification [3][11]. - Key stocks such as Dongfang Caifu, Guotai Junan, Huashan Securities, and CITIC Securities each received over 1 billion yuan in inflows [3][11]. Sector Analysis - The rise in brokerage stocks is attributed to a deep adjustment in valuations since September 2025, coupled with new capital entering the market, industry mergers, and a slight easing of regulatory measures [3][12]. - The overall performance of the brokerage sector in 2025 was lackluster, with the brokerage ETF tracking the CSI All Share Securities Companies Index only increasing by 2.54%, significantly lagging behind the broader market [3][12]. - The price-to-book ratio (PB) for the index was 1.52, placing it in the lower 42.86% percentile historically, indicating a significant divergence from high growth performance [3][12]. Future Outlook - Looking ahead to 2026, the brokerage sector is expected to benefit from trends such as the migration of household deposits, active market trading, and regulatory support for mergers and acquisitions among leading firms [5][14]. - Analysts from Fangzheng Securities and Galaxy Securities predict that the market will maintain high activity levels, with the capital market showing a "healthy bull" trend, driven by wealth management transformation, international business expansion, and financial technology [5][14]. - The brokerage sector's valuations are currently at historical lows, suggesting potential for defensive rebounds [5][14]. Investment Tools - The brokerage ETF (512000) and its linked funds are designed to track the CSI All Share Securities Companies Index, providing an efficient investment tool that encompasses 49 listed brokerage stocks [6][14]. - The brokerage ETF has an average daily trading volume exceeding 1 billion yuan this year, positioning it as a leading liquidity provider in the A-share market [6][14].